gall stonesNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvinggastrointestinal symptomsNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingheadacheNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingimpaired renal functionNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvinglow birthweightNo significant differenceaverage RR 0.93, 95% CI 0.81 to 1.07
and may have little or no effect on low birthweight (less than 2500 g) (average RR 0.93, 95% CI 0.81 to 1.07; 6 trials, 14,162 women; low-certainty evidence)
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingpostpartum haemorrhageNo significant difference
There was no evidence that calcium supplementation had any effect on ... adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingpostpartum hemorrhageNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingpreterm birth less than 34 weeksNo significant differenceaverage RR 1.03, 95% CI 0.79 to 1.35
but probably has little effect on the risk of preterm birth less than 34 weeks (average RR 1.03, 95% CI 0.79 to 1.35; 3 trials, 5569 women; moderate-certainty evidence)
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingpreterm birth less than 37 weeksNo significant differenceaverage RR 0.80, 95% CI 0.65 to 0.99
Calcium supplementation probably slightly reduces the risk of preterm birth less than 37 weeks (average risk ratio (RR) 0.80, 95% confidence interval (CI) 0.65 to 0.99; 11 trials, 15,379 women; moderate-certainty evidence)
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingurinary stonesNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improvingurinary tract infectionNo significant difference
There was no evidence that calcium supplementation had any effect on maternal weight gain during pregnancy; increasing bone mineral density in pregnant women; rate of intrauterine growth restriction; perinatal mortality; stillbirth or fetal death rate; increase birth length or fetal head circumference; and adverse effects such as postpartum haemorrhage, gall stones, gastrointestinal symptoms, headache, urinary stones, urinary tract infection or impaired renal function.
from: Calcium supplementation (other than for preventing or treating hypertension) for improving